Cencora, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 213.99B | 238.59B | 262.17B | 293.96B | 321.33B | 9.3% | |
| Cost of Revenue | (207.72B) | (230.99B) | (254.42B) | (285.26B) | (311.19B) | 9.1% | |
Gross Profit | 6.27B | 7.60B | 7.76B | 8.70B | 10.14B | 16.6% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (3.59B) | (4.85B) | (5.31B) | (5.66B) | (6.49B) | 14.7% | |
| Depreciation & Amortization | (505.17M) | (697.94M) | (972.39M) | (1.11B) | (1.06B) | -4.8% | |
Operating Income (EBIT) | 2.68B | 2.75B | 2.45B | 3.04B | 3.65B | 20.0% | |
| Non-Operating Items | |||||||
| Interest Income | 8.47M | 21.31M | 46.72M | 91.69M | 128.21M | 39.8% | |
| Interest Expense | (182.54M) | (231.98M) | (275.65M) | (248.68M) | (419.75M) | 68.8% | |
| Other Income/Expenses (Net) | -453.15M | -568.62M | -285.68M | -1.04B | -1.39B | 34.1% | |
Income Before Tax | 2.22B | 2.18B | 2.16B | 2.00B | 2.26B | 12.7% | |
| Income Tax Expense | (677.25M) | (516.52M) | (428.26M) | (484.70M) | (690.52M) | 42.5% | |
Net Income | 1.54B | 1.70B | 1.75B | 1.51B | 1.55B | 3.0% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $7 | $8 | $9 | $8 | $8 | 5.5% | |
| Weighted Avg Shares Outstanding | 205.92M | 208.47M | 204.59M | 198.50M | 193.82M | -2.4% | |
| Weighted Avg Shares Outstanding (Diluted) | 208.47M | 211.21M | 204.59M | 200.28M | 195.21M | -2.5% | |
EBITDA | 2.91B | 3.11B | 3.41B | 3.36B | 3.74B | 11.1% |
Explore COR
COR in the Healthcare
Large Cap